Yanguang Hou
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Advances in sulodexide-based long-term anticoagulation for a myasthenia gravis patient with giant thymoma.
Journal: Frontiers in pharmacology
Published: December 11, 2024
FXR promotes clear cell renal cell carcinoma carcinogenesis via MMP-7-regulated EMT pathway.
Journal: Scientific reports
Published: August 08, 2024
Cooperation between SIX1 and DHX9 transcriptionally regulates integrin-focal adhesion signaling mediated metastasis and sunitinib resistance in KIRC.
Journal: Oncogene
Published: February 11, 2024
GHITM regulates malignant phenotype and sensitivity to PD-1 blockade of renal cancer cells via Notch signalling.
Journal: Journal of cellular and molecular medicine
Published: January 28, 2024
DOT1L Epigenetically Regulates Autophagy and Mitochondria Fusion in Cell Lines of Renal Cancer.
Journal: Technology in cancer research & treatment
Published: June 27, 2023
Overcoming the compensatory increase in NRF2 induced by NPL4 inhibition enhances disulfiram/copper-induced oxidative stress and ferroptosis in renal cell carcinoma.
Journal: European journal of pharmacology
Published: May 18, 2023
DOT1L promotes cell proliferation and invasion by epigenetically regulating STAT5B in renal cell carcinoma.
Journal: American journal of cancer research
Published: September 08, 2022
The role of histone methylation in renal cell cancer: an update.
Journal: Molecular biology reports
Published: August 10, 2022
Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma.
Journal: BMC cancer
Published: June 29, 2022
A prognosis model for clear cell renal cell carcinoma based on four necroptosis-related genes.
Journal: Frontiers in medicine
Published: May 13, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026